Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members.
The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process.
In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

See more

Follow us:

0.928 (2018)
1.202 (2017)
0.951 (2016)
0.983 (2015)
1.054 (2014)
0.938 (2013)
0.863 (2012)
0.894 (2011)
Impact Factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

© Clarivate Analytics, Journal Citation Reports 2017 2018

Impact Factor 2018
CiteScore 2018

CiteScore measures average citations received per document published. Read more

CiteScore 2018

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.


SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
Vol. 39. Issue 1.
Pages 1-66 (January - February 2020)
Recommendations for the nomenclature of radiolabeled compounds
I. Peñuelas, A. Lima, M. Mitjavila
Rev Esp Med Nucl Imagen Mol. 2020;39:1-2
Original article
Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma
A. Yanarateş, B. Yazici
Rev Esp Med Nucl Imagen Mol. 2020;39:3-8
The prognostic role of PET/CT in small-cell lung cancer
Emine Budak, Ahmet Yanarateş, Ayşegül Akgün
Rev Esp Med Nucl Imagen Mol. 2020;39:9-13
Role of 18F-FDG PET/CT in the detection of primary malignancy in patients with bone metastasis of unknown origin
Emine Budak, Ahmet Yanarateş
Rev Esp Med Nucl Imagen Mol. 2020;39:14-9
Case reports
False positive in 18F-fluorodeoxyglucose-18F positron emission tomography computed tomography scan of inferior vena cava leiomyoma in patient with a suspected paraganglioma
Antonio Daniel González Jiménez, Antonio Rodríguez Fernández, Rocío Sánchez Sánchez, Fernando Jaén Águila, Juan Diego Mediavilla García, José Manuel Llamas Elvira
Rev Esp Med Nucl Imagen Mol. 2020;39:27-30
Is it possible NET-redifferentiation after chemotherapy? Ga68 DOTA-peptide imaging as a game-changer in therapy management
Nurhan Ergül, Tevfik Fikret Çermik, Nevra Dursun
Rev Esp Med Nucl Imagen Mol. 2020;39:31-4
Interesting images
FDG PET/CT vs. NaF PET/CT in relapsing polychondritis
Yanggang Liu, Yuxiao Xia, Yue Chen, Liang Cai
Rev Esp Med Nucl Imagen Mol. 2020;39:35-6
Prominent pelvic lymph node mimicking a prosthetic hip infection on 99mTc-HMPAO labeled white blood cell scintigraphy
Alessio Rizzo, Valerio Lanni, Teresa Scotognella, Daria Ripani, Vanessa Feudo, Maria Lodovica Maussier
Rev Esp Med Nucl Imagen Mol. 2020;39:37-8
18F-FDG PET/CT findings of a rare case of diffuse hepatic epithelioid hemangioendothelioma with bone metastases at diagnosis
Salih Ozguven, Selin Kesim, Kevser Oksuzoglu, Faysal Dane, Tunc Ones, Tanju Yusuf Erdil
Rev Esp Med Nucl Imagen Mol. 2020;39:39-40
Nonfunctioning paraganglioma incidentally detected by 18F-FDG PET/CT and confirmed by 123I-MIBG M scintigraphy
Rexhep Durmo, Domenico Albano, Valentina Crisafulli, Fabrizia Terraneo, Raffaele Giubbini, Francesco Bertagna
Rev Esp Med Nucl Imagen Mol. 2020;39:41-2
Vaginal metastasis from rectal cancer detected by 18F-FDG PET/CT
Qiuping Fan, Dongqiong Huang, Minggang Su
Rev Esp Med Nucl Imagen Mol. 2020;39:43-4
Incremental value of 18F-fluorocholine PET/CT in comparison with 68Ga-DOTA PET/CT in adrenal adenoma localization in a MEN1 patient
Yuxiao Xia, Zi Wang, Yanhong Zhao, Huipan Liu, Yue Chen
Rev Esp Med Nucl Imagen Mol. 2020;39:45-6
Detection of multicentric osteoid osteoma in parietal and rib bones by 18F-NaF PET/CT
Huipan Liu, Yanhong Zhao, Yuxiao Xia, Zi Wang, Yue Chen
Rev Esp Med Nucl Imagen Mol. 2020;39:47-8
Detection of potential lesions of Schwannomatosis visualized on 18F-FDG PET/CT
Yuxiao Xia, Jie Zhang, YanHong Zhao, HuiPan Liu, Zi Wang, Yue Chen
Rev Esp Med Nucl Imagen Mol. 2020;39:49-50
Special collaboration
Criteria of metabolic response to immunotherapy
Jorge Mucientes Rasilla, Lourdes Gutiérrez Sanz
Rev Esp Med Nucl Imagen Mol. 2020;39:51-6
Continuing education
FDG PET/CT in colorectal cancer
M. Rodríguez-Fraile, M.P. Cózar-Santiago, A. Sabaté-Llobera, A.P. Caresia-Aróztegui, R.C. Delgado-Bolton, J. Orcajo-Rincon, M. de Arcocha-Torres, M.J. García-Velloso, P. García-Talavera
Rev Esp Med Nucl Imagen Mol. 2020;39:57-66
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.